Clinical findings associated with N‐terminal pro‐B‐type natriuretic peptide measurement in dogs and cats attending first opinion veterinary practices
Authors:
Open Access
- 23 September 2021
- journal article
- research article
- Published by Wiley in Veterinary Record
- Vol. 191 (2) , e945
Abstract
Background: Clinical findings associated with N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) measurement in dogs and cats in primary practice, and their relevance to published measurement indications, have not been described. Methods: Using electronic health record data collected by the Small Animal Veterinary Surveillance Network, appointments in which NT‐proBNP was measured were identified using keyword‐based text filtering. For these appointments, clinical findings were manually identified from each patient's clinical narrative (CN) and their frequencies described. Results: CNs of 3510 appointments (357 dogs and 257 cats) from 99practices were evaluated. The most frequently recorded clinical findings in dogs were: heart murmur ( n = 147, 41.2% (95% confidence interval (CI) = 36.1%–46.3%), coughing ( n = 83, 23.2% (95% CI = 18.8%–27.6%)) and panting ( n = 58, 16.2% (95% CI = 12.4%–20.0%)) and in cats: heart murmur ( n = 143, 55.6% (95% CI = 49.5%–61.7%)), suspected thromboembolism ( n = 88, 34.2% (95% CI = 28.4%–40.0%)) and weight loss ( n = 53, 20.6% (95% CI = 15.7%–25.5%)). Dyspnoea and tachypnoea were infrequently reported in dogs ( n = 29, 8.1% (95% CI = 5.3%–10.9%) and n = 21, 5.9% (95% CI = 3.5%–8.3%), respectively) and cats ( n = 26, 10.1% (95% CI = 6.4%–13.8%) and n = 36, 14.0% (95% CI = 9.8%–18.2%), respectively). Conclusion: Clinical findings referable to cardiac disease were recorded contemporaneously with NT‐proBNP measurement and suggested both published and other indications (coughing (in dogs and cats), and serial measurements and thromboembolism (in cats)) for testing.Keywords
This publication has 34 references indexed in Scilit:
- Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: The PREDICT cohort studyJournal of Veterinary Cardiology, 2012
- Multicenter Evaluation of Plasma N-Terminal Probrain Natriuretic Peptide (NT-pro BNP) as a Biochemical Screening Test for Asymptomatic (occult) Cardiomyopathy in CatsJournal of Veterinary Internal Medicine, 2011
- Evaluation of N-terminal pro-B-type natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Doberman PinschersAmerican Journal of Veterinary Research, 2011
- Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005)Journal of Small Animal Practice, 2010
- Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogsJournal of the American Veterinary Medical Association, 2009
- Association of Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration with Mitral Regurgitation Severity and Outcome in Dogs with Asymptomatic Degenerative Mitral Valve DiseaseJournal of Veterinary Internal Medicine, 2009
- Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in catsJournal of Veterinary Cardiology, 2009
- Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary diseaseJournal of the American Veterinary Medical Association, 2008
- The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac diseaseJournal of Small Animal Practice, 2007
- Arterial Thromboembolism in Cats: Acute Crisis in 127 Cases (1992–2001) and Long-Term Management with Low-Dose Aspirin in 24 CasesJournal of Veterinary Internal Medicine, 2003